JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 6, 2006; DOI: 10.1124/jpet.106.106526


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.106526v1
318/3/974    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prinster, S. C.
Right arrow Articles by Hall, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prinster, S. C.
Right arrow Articles by Hall, R. A.


Received for publication April 20, 2006.
Revised June 2, 2006.
Accepted for publication June 2, 2006.

Alpha-2C-adrenergic receptors exhibit enhanced surface expression and signaling upon association with beta-2-adrenergic receptors

Steven C. Prinster 1, Tomas G. Holmqvist 1, Randy A. Hall 1*

1 Emory University School of Medicine

* Address correspondence to: E-mail: rhall{at}pharm.emory.edu

Abstract

The alpha-2C-adrenergic receptor (alpha2C-AR) is known to be poorly trafficked to the cell surface when expressed in a variety of cell types. We tested the hypothesis that the surface expression and signaling of alpha2C-AR might be enhanced by heterodimerization with other G protein-coupled receptors (GPCRs). Co-transfection of alpha2C-AR with more than twenty-five related GPCRs revealed that only co-expression with the beta-2-adrenergic receptor (beta2-AR) increased the surface localization of alpha2C-AR in HEK-293 cells. Co-immunoprecipitation of alpha2C-AR with beta2-AR confirmed a physical interaction between the two receptors. Confocal microscopy studies demonstrated that alpha2C-AR expressed alone was mainly intracellular, whereas alpha2C-AR co-expressed with beta2-AR was predominantly localized to the plasma membrane. Ligand binding studies revealed a significant increase in alpha2C-AR binding sites upon co-expression with beta2-AR, with no apparent change in affinity for alpha2-AR ligands. Functional assays with the alpha2-AR-specific agonist UK 14,304 revealed that co-expression of beta2-AR with alpha2C-AR enhanced alpha2C-AR-mediated activation of ERK 1/2. Furthermore, analyses of agonist-promoted receptor endocytosis demonstrated enhanced alpha2C-AR internalization in response to alpha2-AR agonists when alpha2C-AR and beta2-AR were co-expressed. Additionally, substantial co-internalization of alpha2C-AR in response to beta-AR agonists was observed when alpha2C-AR was co-expressed with beta2-AR. These data reveal that alpha2C-AR can interact with beta2-AR in cells in a manner that regulates alpha2C-AR surface expression, internalization, and functionality.


Key words: adrenoceptor, dimerization, epinephrine, norepinephrine, oligomerization, trafficking


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. F. Bush, S. V. Jones, A. N. Lyle, K. P. Minneman, K. J. Ressler, and R. A. Hall
Specificity of Olfactory Receptor Interactions with Other G Protein-coupled Receptors
J. Biol. Chem., June 29, 2007; 282(26): 19042 - 19051.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Salim, K. M. Standifer, and D. C. Eikenburg
Extracellular Signal-Regulated Kinase 1/2-Mediated Transcriptional Regulation of G-Protein-Coupled Receptor Kinase 3 Expression in Neuronal Cells
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 51 - 59.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.